Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era
- PMID: 28260651
- PMCID: PMC5474203
- DOI: 10.1016/j.cbpa.2017.02.005
Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era
Abstract
In the past 15 years, the cost of sequencing a genome has plummeted. Consequently, the number of sequenced bacterial genomes has exponentially increased, and methods for natural product discovery have evolved rapidly to take advantage of the wealth of genomic data. This review highlights applications of genome mining software to compare and organize large-scale data sets and methods for identifying unique biosynthetic pathways amongst the thousands of ribosomally synthesized and post-translationally modified peptide (RiPP) gene clusters. We also discuss a small number of the many RiPPs discovered in the years 2014-2016.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Figures
References
-
- Tsomaia N. Peptide therapeutics: Targeting the undruggable space. Eur J Med Chem. 2015;94:459–470. - PubMed
-
- Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3:238–250. - PubMed
-
- Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep. 2013;30:108–160. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
